At Torigen, we are making strides in ACV technology. We create a personalized vaccine with a unique MIM-SIS adjuvant for companion animals that is available for commercial sale for any type of solid tumor.
Torigen recently published an article entitled “Equine Immuno-Oncology Gallops Ahead” in the Midwest Grazer Spring/Summer 2024 magazine.
We recently had a chance to interview Christie, our External Innovation & Clinical Trials Manager! She gives us some insight into her role at Torigen.
2023 has been a year of growth and success for Torigen, and we are happy to be reflecting on it.
According to the American Veterinary Medical Association, 1 in 4 dogs and 1 in 5 cats will develop cancer in their lifetimes. Thankfully, veterinarians suggest that many forms of cancer can be put into remission with early and appropriate intervention.
Torigen started as just an idea that was forged from grit, elbow-grease, novel technology and spun out of the University of Notre Dame into a company focused on helping animals with cancer. To me, Torigen is so much more. At one point, Torigen didn’t exist. Just like Google, Amazon or Pfizer, brands that we all recognize as industry game-changers, we started with just a technology and a dream.
Are you proud to offer Torigen’s Experimental Autologous Prescription Product in your practice but not sure how to share the news with your customers? We have a solution.
Uncertainty in veterinary medicine is inevitable and causes stress for both you and your client. For veterinarians, uncertainty may create self-doubt, feelings of inferiority, and emotional insecurity.
We recently had a chance to interview Kelly, one of our technicians who processes the vaccines! She gives us some insight into what a typical day looks like as a technician at Torigen.
Cancer immunotherapy is one of the most exciting advances in veterinary medicine. With so many recent therapeutic innovations it’s challenging to keep up. Here’s a brief overview of cancer immunology to quickly get you up to speed.
While horses are less frequently diagnosed with cancer compared to humans, dogs, and cats, it is imperative to understand the threat cancer poses to your clients' cherished steed, favorite yard ornament, and adventure buddy.
April has been such an exciting, whirlwind month for Torigen, but we could not be happier with the progress and momentum we are building as we close out the first third of 2023!
For veterinarians, it is important to share the warning signs of cancer in cats to help get more of our feline friends treated earlier.
Torigen strives to collaborate with veterinarians early in the cancer diagnostic process so that our teams can work together to find the best path forward for the patient.
2022 was an amazing year at Torigen filled with continued growth and success.
Excellent communication between clients and the veterinary cancer care team is vital for the best patient outcomes regardless of diagnosis.
Millions of dogs and cats are diagnosed with cancer each year. Although interest in oncology referral is growing, some pet owners will elect against it. The reasons for referral refusal are varied.
Timely diagnosis and treatment of cancer in the veterinary patient is required to improve both patient comfort and prognosis. Members of the cancer care team have responsibilities to each cancer patient that vary depending on the individual circumstances.
Proper diagnosis of cancer is paramount in oncology to improve patient comfort and prognosis. The growing field of oncology can appear extremely complex. However, it can be broken down into a few simple, yet extremely important questions.
Torigen’s Chief Executive Officer, Ashley Kalinauskas, was featured on 1080 WTIC NEWSTALK, News You Can Use with Ann Baldwin, to discuss Torigen’s history and mission in the veterinary field.
Treatment for cancer in pets typically comes in three forms: surgery, chemotherapy, and radiation therapy. While these treatment methods do have high rates of success, they can be incredibly invasive and can have negative side-effects.
As with cancer in humans, pets have the most success for treatment and remission if cancer is caught early in its development. Luckily, there are common signs to look out for in your dog that can be indicators of illness or cancer.
Over 50% of dogs over the age of 10 dies from cancer and Bo was stricken with hemangiosarcoma, one of the most aggressive forms of dog cancer.
At Torigen, we understand that veterinary clinics are experiencing a phenomenally high demand. As essential workers, we want to thank you. We recognize that working in a COVID world is both mentally and physically draining. Interacting with clients who are just as frustrated as you are and in the face of pressure aren’t their normal selves only makes you feel overwhelmed by world circumstances that are out of your control. We hear You!
Ashley Kalinauskas is the founder and CEO of Torigen Pharmaceuticals, a company dedicated to researching immuno-oncology in the veterinary market. Follow along here as we interview Ashley to learn what it’s like being on the forefront of veterinary oncology and the commercialization of their experimental immunotherapy. Read more